Demo Data from SIGIR 2026 / reviewers in the wild / expert
Mehmet Ozcan
dblp:370/6049
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2023
0000-0002-1222-2802ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 3, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery
drug mode of action analysis |
0.7 | 1 | 2023 | Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy · Bioinform. 2023 |
Bioinformatics and computational biology › drug discovery
drug repositioning |
0.7 | 1 | 2023 | Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy · Bioinform. 2023 |
Bioinformatics and computational biology › multi-omics data integration
multi-omics network integration |
0.7 | 1 | 2023 | Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy · Bioinform. 2023 |
Methods — techniques the papers use, named apart from their topics
network topology analysis · 0.7confidence scoring · 0.7
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2023 | Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchyabstractMOTIVATION: Many approaches in systems biology have been applied in drug repositioning due to the increased availability of the omics data and computational biology tools. Using a multi-omics integrated network, which contains information of various biological interactions, could offer a more comprehensive inspective and interpretation for the drug mechanism of action (MoA). RESULTS: We developed a computational pipeline for dissecting the hidden MoAs of drugs (Open MoA). Our pipeline computes confidence scores to edges that represent connections between genes/proteins in the integrated network. The interactions showing the highest confidence score could indicate potential drug targets and infer the underlying molecular MoAs. Open MoA was also validated by testing some well-established targets. Additionally, we applied Open MoA to reveal the MoA of a repositioned drug (JNK-IN-5A) that modulates the PKLR expression in HepG2 cells and found STAT1 is the key transcription factor. Overall, Open MoA represents a first-generation tool that could be utilized for predicting the potential MoA of repurposed drugs and dissecting de novo targets for developing effective treatments. AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/XinmengLiao/Open_MoA. Xinmeng Liao, Mehmet Ozcan, Woonghee Kim, Hasan Turkez, Adnane Achour, Mathias Uhlen, Adil Mardinoglu, Cheng Zhang 0002 |
Bioinform. | 2 |